RJA
CSII

Raymond James & Associates’s Cardiovascular Systems, Inc. CSII Stock Holding History

Raymond James & Associates’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,261
Closed -$256K – 3781
2019
Q4 		$256K Sell
5,261
-4,141
-44% -$189K ﹤0.01% 3182
2019
Q3 		$447K Buy
9,402
+4,191
+80% +$197K ﹤0.01% 2728
2019
Q2 		$224K Buy
+5,211
New +$202K ﹤0.01% 3183

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's CSII Position: Q1 2020 in Review

Raymond James & Associates sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2020, closing a stake of 5,261 shares — an estimated $256K sold.

Raymond James & Associates first reported a position in CSII in Q2 2019 and held it in 3 quarters. The position peaked at $447K in Q3 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q1 2020.

  • Raymond James & Associates reported no remaining Cardiovascular Systems, Inc. position as of Q1 2020 after selling out during the quarter.
  • Raymond James & Associates sold 5,261 Cardiovascular Systems, Inc. shares in Q1 2020, an estimated $256K.
  • Raymond James & Associates first reported a position in Cardiovascular Systems, Inc. in Q2 2019 and held it in 3 quarters.
  • Raymond James & Associates's Cardiovascular Systems, Inc. position peaked at $447K in Q3 2019.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2020.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.